These injectable medications are helping people eat less, lose weight and improve their overall health
Research suggests microdosing may help correct blood sugar instability and insulin sensitivity even before significant weight loss occurs
GLP-1s were originally developed to treat diabetes and obesity, but researchers at the University of Colorado Anschutz have found that the drugs increased brain connectivity in some patients and may rewire brains beyond quieting appetites, researchers told the Washington Post
By purchasing, you acknowledge that you have read, understood, and agreed to this disclaimer.
The authors searched for randomised clinicals trials of GLP-1 RA medications (albiglutide, dulaglutide, exenatide, liraglutide, lixisenatide, or semaglutide) that also reported adverse events of gallbladder or biliary diseases